The road of domestic pharmaceutical machinery transformation: to the high-end technology

The road of domestic pharmaceutical machinery transformation: to the high-end technology

From the current point of view, although China's pharmaceutical machinery industry has made certain progress, there are still certain problems in the development process. For example, low-grade products are flooding the dominant market, and a small part of high-end, high-precision, high-strength pharmaceutical equipment still needs Import; incomplete product structure, oversupply of products in the low-end market, etc. In this regard, experts said that domestic pharmaceutical machinery needs to work towards high-end technology to achieve transformation and upgrading.

Low-end products are still flooding the pharmaceutical machinery market

Although the domestic pharmaceutical machinery industry has made great progress, there are still many problems. The market order is chaotic; the product structure is incomplete, and the supply of products in the low-end market exceeds demand; the technical level of the enterprise is relatively low, and the independent research and development and independent innovation capabilities are not strong. These problems have greatly hindered the healthy development of the pharmaceutical machinery industry.

From the current point of view, domestic pharmaceutical machinery production is still dominating the market for low-grade products. A small portion of high-end, high-precision, high-strength pharmaceutical machinery equipment still needs to be imported. The ratio between the unit price of imported products and the unit price of exports is more than 6 times. There is a large gap with the United States, Japan, South Korea, and Taiwan, and there is a lack of technical services to solve mechanical fastening solutions, to achieve the digitalization of products, design, manufacturing, and management, and the greening of products and manufacturing processes.

Compared with the foreign pharmaceutical machinery industry, the domestic pharmaceutical machinery industry has certain advantages and gaps. Compared with the western pharmaceutical machinery industry, China's pharmaceutical machinery industry has two major competitive advantages: on the one hand, it has a low-cost competitive advantage; on the other hand, the implementation of the new version of GMP in China, the rapid growth of the pharmaceutical machinery market The development of the machinery industry provides important support. China's continuously growing market space is a prerequisite for the domestic industry to maintain its advantages.

The road of domestic pharmaceutical machinery transformation: to develop high-end technology

At present, all economic indicators of China's pharmaceutical machinery industry have declined, including new orders and production and sales levels. At the same time, the substantial increase in capital occupancy also created a lot of idle resources, reducing efficiency. Against the backdrop of the current macroeconomic downturn, companies need to break through the difficulties and reverse the situation. The road to transformation is very clear, that is, to force high-end technology.

In the past few years, the technology development trend of China's pharmaceutical machinery industry has become more and more consistent with the technology development of its counterparts in the world, but the overall technical level is relatively low. Therefore, research and development of high-end products adapted to China's domestic market has become a shortcut for the survival of China's pharmaceutical machinery enterprises.